NM_001144382.2:c.3019-11369A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001144382.2(PLCL2):c.3019-11369A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.597 in 152,098 control chromosomes in the GnomAD database, including 27,565 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 27565 hom., cov: 32)
Consequence
PLCL2
NM_001144382.2 intron
NM_001144382.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.510
Publications
17 publications found
Genes affected
PLCL2 (HGNC:9064): (phospholipase C like 2) Enables GABA receptor binding activity. Predicted to be involved in negative regulation of cold-induced thermogenesis and phosphatidylinositol-mediated signaling. Predicted to act upstream of or within several processes, including B cell activation; gamma-aminobutyric acid signaling pathway; and negative regulation of B cell receptor signaling pathway. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.701 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLCL2 | ENST00000615277.5 | c.3019-11369A>G | intron_variant | Intron 3 of 5 | 1 | NM_001144382.2 | ENSP00000478458.1 | |||
PLCL2 | ENST00000432376.5 | c.2641-11369A>G | intron_variant | Intron 3 of 5 | 1 | ENSP00000412836.1 | ||||
PLCL2 | ENST00000419842.1 | c.1870-11369A>G | intron_variant | Intron 2 of 4 | 2 | ENSP00000404433.1 |
Frequencies
GnomAD3 genomes AF: 0.596 AC: 90627AN: 151978Hom.: 27520 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
90627
AN:
151978
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.597 AC: 90737AN: 152098Hom.: 27565 Cov.: 32 AF XY: 0.601 AC XY: 44660AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
90737
AN:
152098
Hom.:
Cov.:
32
AF XY:
AC XY:
44660
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
29397
AN:
41506
American (AMR)
AF:
AC:
8679
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
1793
AN:
3470
East Asian (EAS)
AF:
AC:
3297
AN:
5166
South Asian (SAS)
AF:
AC:
3138
AN:
4820
European-Finnish (FIN)
AF:
AC:
6773
AN:
10592
Middle Eastern (MID)
AF:
AC:
151
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35588
AN:
67968
Other (OTH)
AF:
AC:
1230
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1875
3751
5626
7502
9377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2344
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.